 Thomas Bak
Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 21 | 2016 | 847 | 0.920 |
Why?
| | Living Donors | 7 | 2008 | 319 | 0.340 |
Why?
| | Hepatic Artery | 3 | 2004 | 55 | 0.330 |
Why?
| | Carcinoma, Hepatocellular | 5 | 2007 | 227 | 0.290 |
Why?
| | Intestinal Fistula | 1 | 2004 | 12 | 0.260 |
Why?
| | Duodenal Diseases | 1 | 2004 | 10 | 0.260 |
Why?
| | Vascular Fistula | 1 | 2004 | 16 | 0.260 |
Why?
| | Aneurysm, False | 1 | 2004 | 46 | 0.250 |
Why?
| | Liver Neoplasms | 5 | 2007 | 527 | 0.250 |
Why?
| | Immunosuppressive Agents | 8 | 2008 | 681 | 0.230 |
Why?
| | Cholangitis, Sclerosing | 4 | 2008 | 75 | 0.180 |
Why?
| | Sirolimus | 3 | 2007 | 195 | 0.140 |
Why?
| | Liver Failure | 2 | 2008 | 85 | 0.140 |
Why?
| | Airway Extubation | 1 | 2016 | 45 | 0.130 |
Why?
| | Donor Selection | 1 | 2016 | 73 | 0.130 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2016 | 124 | 0.130 |
Why?
| | Tissue Donors | 1 | 2016 | 336 | 0.120 |
Why?
| | Cholestasis | 1 | 2016 | 228 | 0.110 |
Why?
| | Graft Rejection | 3 | 2007 | 555 | 0.100 |
Why?
| | Tacrolimus | 3 | 2007 | 151 | 0.100 |
Why?
| | Hypoxia | 1 | 2016 | 963 | 0.090 |
Why?
| | Graft Survival | 5 | 2016 | 504 | 0.090 |
Why?
| | Hepatitis, Autoimmune | 1 | 2008 | 33 | 0.080 |
Why?
| | Hepatic Veins | 1 | 2008 | 31 | 0.080 |
Why?
| | Chemoembolization, Therapeutic | 2 | 2007 | 51 | 0.080 |
Why?
| | Cadaver | 3 | 2004 | 327 | 0.080 |
Why?
| | Hepatectomy | 1 | 2008 | 139 | 0.080 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2006 | 39 | 0.070 |
Why?
| | Disease Transmission, Infectious | 1 | 2006 | 56 | 0.070 |
Why?
| | Portal Vein | 1 | 2006 | 90 | 0.070 |
Why?
| | Tissue and Organ Procurement | 3 | 2004 | 248 | 0.070 |
Why?
| | Herpes Simplex | 1 | 2006 | 90 | 0.070 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 521 | 0.060 |
Why?
| | Venous Thrombosis | 1 | 2006 | 147 | 0.060 |
Why?
| | Middle Aged | 15 | 2016 | 27617 | 0.060 |
Why?
| | Vena Cava, Inferior | 1 | 2004 | 55 | 0.060 |
Why?
| | Reoperation | 3 | 2016 | 557 | 0.060 |
Why?
| | Survival Analysis | 4 | 2008 | 1267 | 0.060 |
Why?
| | Hepatocytes | 1 | 2003 | 205 | 0.050 |
Why?
| | Treatment Outcome | 7 | 2016 | 9342 | 0.050 |
Why?
| | Hospital Costs | 1 | 2003 | 110 | 0.050 |
Why?
| | Adult | 11 | 2016 | 31512 | 0.050 |
Why?
| | Female | 16 | 2016 | 61564 | 0.050 |
Why?
| | Vascular Surgical Procedures | 1 | 2004 | 262 | 0.050 |
Why?
| | Hepatitis C | 1 | 2003 | 217 | 0.050 |
Why?
| | Pancreas Transplantation | 1 | 2000 | 68 | 0.050 |
Why?
| | Retrospective Studies | 8 | 2016 | 12978 | 0.050 |
Why?
| | Humans | 22 | 2016 | 118972 | 0.040 |
Why?
| | Recurrence | 3 | 2008 | 975 | 0.040 |
Why?
| | Male | 16 | 2016 | 57801 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2003 | 545 | 0.040 |
Why?
| | Disease-Free Survival | 2 | 2008 | 649 | 0.040 |
Why?
| | Time Factors | 3 | 2016 | 6412 | 0.030 |
Why?
| | Risk Factors | 4 | 2016 | 9000 | 0.030 |
Why?
| | Shock | 1 | 2016 | 91 | 0.030 |
Why?
| | Health Care Rationing | 2 | 2004 | 48 | 0.030 |
Why?
| | Erythrocyte Transfusion | 1 | 2016 | 210 | 0.030 |
Why?
| | Follow-Up Studies | 3 | 2008 | 4596 | 0.030 |
Why?
| | Cause of Death | 1 | 2016 | 380 | 0.030 |
Why?
| | Hemoglobins | 1 | 2016 | 326 | 0.030 |
Why?
| | Cyclosporine | 2 | 2003 | 173 | 0.030 |
Why?
| | Neoplasm Staging | 2 | 2007 | 1223 | 0.030 |
Why?
| | Cohort Studies | 3 | 2008 | 5116 | 0.020 |
Why?
| | Patient Selection | 2 | 2004 | 676 | 0.020 |
Why?
| | Liver | 2 | 2007 | 1816 | 0.020 |
Why?
| | Adolescent | 3 | 2016 | 18480 | 0.020 |
Why?
| | Tissue and Organ Harvesting | 1 | 2008 | 67 | 0.020 |
Why?
| | Functional Laterality | 1 | 2008 | 208 | 0.020 |
Why?
| | Portography | 1 | 2006 | 13 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 2 | 2006 | 2436 | 0.020 |
Why?
| | Delayed-Action Preparations | 1 | 2007 | 161 | 0.020 |
Why?
| | Ultrasonics | 1 | 2006 | 53 | 0.020 |
Why?
| | Simplexvirus | 1 | 2006 | 86 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2007 | 462 | 0.020 |
Why?
| | Colorado | 2 | 2008 | 4196 | 0.020 |
Why?
| | Blood Vessels | 1 | 2007 | 187 | 0.020 |
Why?
| | Biomarkers | 1 | 2016 | 3588 | 0.020 |
Why?
| | Treatment Failure | 1 | 2006 | 341 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2006 | 160 | 0.020 |
Why?
| | Safety | 1 | 2007 | 304 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2008 | 842 | 0.020 |
Why?
| | Aged | 3 | 2008 | 19657 | 0.020 |
Why?
| | Preoperative Care | 1 | 2007 | 332 | 0.020 |
Why?
| | Waiting Lists | 1 | 2006 | 228 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2008 | 1125 | 0.020 |
Why?
| | Survival | 1 | 2004 | 39 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2000 | 3360 | 0.020 |
Why?
| | alpha-Fetoproteins | 1 | 2004 | 33 | 0.020 |
Why?
| | Transplants | 1 | 2004 | 36 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 2003 | 59 | 0.010 |
Why?
| | Muromonab-CD3 | 1 | 2003 | 23 | 0.010 |
Why?
| | Outpatients | 1 | 2006 | 325 | 0.010 |
Why?
| | Cost Control | 1 | 2003 | 44 | 0.010 |
Why?
| | Alkaline Phosphatase | 1 | 2003 | 157 | 0.010 |
Why?
| | Bile Ducts | 1 | 2003 | 73 | 0.010 |
Why?
| | Cost Savings | 1 | 2003 | 77 | 0.010 |
Why?
| | Postoperative Complications | 2 | 2004 | 2235 | 0.010 |
Why?
| | Hospitals, University | 1 | 2003 | 172 | 0.010 |
Why?
| | Ultrasonography | 1 | 2006 | 716 | 0.010 |
Why?
| | Child | 2 | 2016 | 19129 | 0.010 |
Why?
| | Aspartate Aminotransferases | 1 | 2002 | 95 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2007 | 900 | 0.010 |
Why?
| | Alanine Transaminase | 1 | 2002 | 152 | 0.010 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2000 | 27 | 0.010 |
Why?
| | Incidence | 1 | 2007 | 2424 | 0.010 |
Why?
| | Young Adult | 1 | 2016 | 10793 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2003 | 1474 | 0.010 |
Why?
| | Risk Assessment | 1 | 2008 | 3057 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 1998 | 146 | 0.010 |
Why?
| | Liver Failure, Acute | 1 | 1998 | 63 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 1868 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2002 | 1945 | 0.010 |
Why?
| | Age Factors | 1 | 2004 | 2995 | 0.010 |
Why?
| | Prevalence | 1 | 2003 | 2326 | 0.010 |
Why?
| | Models, Biological | 1 | 2003 | 1715 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2003 | 2674 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 3174 | 0.010 |
Why?
| | Diabetes Mellitus | 1 | 2003 | 942 | 0.010 |
Why?
| | Child, Preschool | 1 | 2004 | 9491 | 0.010 |
Why?
| | Obesity | 1 | 2003 | 2746 | 0.010 |
Why?
|
|
Bak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|